These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 29852147

  • 1. Pericardial and Pleural Metastases: Clinical, Histologic, and Molecular Differences.
    Karpathiou G, Mobarki M, Stachowicz ML, Hathroubi S, Patoir A, Tiffet O, Froudarakis M, Peoc'h M.
    Ann Thorac Surg; 2018 Sep; 106(3):872-879. PubMed ID: 29852147
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
    Pan Y, Zhang Y, Li Y, Hu H, Wang L, Li H, Wang R, Ye T, Luo X, Zhang Y, Li B, Cai D, Shen L, Sun Y, Chen H.
    Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis.
    Rodriguez EF, Shabihkhani M, Carter J, Maleki Z.
    Acta Cytol; 2017 May; 61(3):214-222. PubMed ID: 28538219
    [Abstract] [Full Text] [Related]

  • 6. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor.
    Pokieser W, Cassik P, Fischer G, Vesely M, Ulrich W, Peters-Engl C.
    Breast Cancer Res Treat; 2004 Jan; 83(2):139-42. PubMed ID: 14997044
    [Abstract] [Full Text] [Related]

  • 7. EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
    Forest F, Stachowicz ML, Casteillo F, Karpathiou G, Gouzy-Grosjean F, Guilaubey C, Cottier M, Beal J, Clemenson A, Péoc'h M.
    Exp Mol Pathol; 2017 Dec; 103(3):306-310. PubMed ID: 29175303
    [Abstract] [Full Text] [Related]

  • 8. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
    Schweiger T, Hegedüs B, Nikolowsky C, Hegedüs Z, Szirtes I, Mair R, Birner P, Döme B, Lang G, Klepetko W, Ankersmit HJ, Hoetzenecker K.
    Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
    [Abstract] [Full Text] [Related]

  • 9. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G, Wong R, Chhieng D, Levy GH, Gettinger SN, Herbst RS, Puchalski JT, Homer RJ, Hui P.
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [Abstract] [Full Text] [Related]

  • 10. Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.
    Tsai TH, Wu SG, Hsieh MS, Yu CJ, Yang JC, Shih JY.
    Lung Cancer; 2015 May; 88(2):208-14. PubMed ID: 25773866
    [Abstract] [Full Text] [Related]

  • 11. Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
    Dormieux A, Mezquita L, Cournede PH, Remon J, Tazdait M, Lacroix L, Rouleau E, Adam J, Bluthgen MV, Facchinetti F, Tselikas L, Aboubakar F, Naltet C, Lavaud P, Gazzah A, Le Pechoux C, Lassau N, Balleyguier C, Planchard D, Besse B, Caramella C.
    Eur Radiol; 2020 Sep; 30(9):5021-5028. PubMed ID: 32323012
    [Abstract] [Full Text] [Related]

  • 12. High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
    Thomas A, Chen Y, Steinberg SM, Luo J, Pack S, Raffeld M, Abdullaev Z, Alewine C, Rajan A, Giaccone G, Pastan I, Miettinen M, Hassan R.
    Oncotarget; 2015 May 10; 6(13):11694-703. PubMed ID: 26028668
    [Abstract] [Full Text] [Related]

  • 13. [Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].
    Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi F.
    Rev Mal Respir; 2016 Nov 10; 33(9):751-756. PubMed ID: 27017063
    [Abstract] [Full Text] [Related]

  • 14. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
    Park J, Kobayashi Y, Urayama KY, Yamaura H, Yatabe Y, Hida T.
    PLoS One; 2016 Nov 10; 11(8):e0161081. PubMed ID: 27518729
    [Abstract] [Full Text] [Related]

  • 15. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
    Zhao C, Li X, Su C, Li J, Cheng N, Ren S, Chen X, Zhou C.
    Int J Clin Exp Pathol; 2015 Nov 10; 8(3):3104-9. PubMed ID: 26045824
    [Abstract] [Full Text] [Related]

  • 16. Serous effusions in malignant lymphomas: a review.
    Das DK.
    Diagn Cytopathol; 2006 May 10; 34(5):335-47. PubMed ID: 16604559
    [Abstract] [Full Text] [Related]

  • 17. Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer.
    Kuijpers CCHJ, Hendriks LEL, Derks JL, Dingemans AC, van Lindert ASR, van den Heuvel MM, Damhuis RA, Willems SM.
    Lung Cancer; 2018 Jul 10; 121():76-81. PubMed ID: 29858031
    [Abstract] [Full Text] [Related]

  • 18. Malignant pleural effusions after resection of pulmonary adenocarcinoma.
    Renshaw AA, Madge R, Sugarbaker DJ, Swanson S.
    Acta Cytol; 1998 Jul 10; 42(5):1111-5. PubMed ID: 9755666
    [Abstract] [Full Text] [Related]

  • 19. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K, Sima CS, Arcila ME, Hedvat C, Kris MG, Jones DR, Adusumilli PS, Travis WD.
    Am J Surg Pathol; 2016 Dec 10; 40(12):1579-1590. PubMed ID: 27740967
    [Abstract] [Full Text] [Related]

  • 20. [Frequency of adenocarcinomas in serous effusions].
    Longatto Filho A, Bisi H, Bortolan J, Lombardo V, Alves VA.
    Rev Assoc Med Bras (1992); 1999 Dec 10; 45(4):327-36. PubMed ID: 10752240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.